SEC Form 4 · accession 0001485003-16-000178
Sesen Bio, Inc. · SESN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur DeCillis
Officer — Chief Medical Officer
Period of report
Sep 20, 2016
Accepted (ET)
Sep 22, 2016 · 4:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001485003
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $3.37 | Sep 20, 2016 | A | 100,000 | A | — | Sep 19, 2026 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F125% of the shares subject to such option shall vest on the first anniversary of the date of grant of the option and an additional 6.25% of the shares underlying the option shall vest at the end of each successive three-month period thereafter until the fourth anniversary of the date of grant of the option.